Inovio Pharma (INO) Reports Q2 Loss of $0.83/sh
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.18 -2.48%
Financial Fact:
General and administrative: 5.76M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative: 5.76M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.83), versus ($0.30) reported last year. Revenue for the quarter came in at $237 thousand, versus $135.7 thousand reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
